RE:RE:RE:Bird flu emergency.Theralase is already in hot pursuit of a bird flu solution by way of a Collaborative Research Agreement with the government of Canada and the University if Manitoba.
"Theralase® in conjunction with UM and PHAC have modified their focus to avian influenza (H5N1). These results have now laid the groundwork for the next phase of the CRA, which is evaluating the Theralase® H5N1 vaccine in the ability to prevent animals from contracting H5N1, when exposed to the virus, which commenced in 2Q2024 and is expected to be completed by 2Q2025."
rollthedice10 wrote: Don't know if TLT has the time or resources to be chasing bird flu
right now. I'm happy to see TLT keep thier focus on Cancer and continue
moving forward with that. The big vaccine players are no doubt all over the flu
thing anyway. Focus.I have seen too many plays go sour when management
loses focus or overextends themselves.
TLT has come a long way and has incredible data in regard to Cancers and
I think we are likely going into a " final lap " in that regard. Focus.
When TLT has more resources they can explore other markets butcha gotta
walk before you can run. JMHO